BRIVARACETAM |
BRIVARACETAM : Inhibitor of SV2A
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SV2A |
|
|
Inhibitor
1–10 μM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Brivaracetam was profiled at 10 μM (a concentration > 100 fold higher than its affinity for SV2A) ag ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Results from SV2A−/− knock-out mice clearly show that up to concentrations of 600 nm, [3H]BRV specif ...
Potency Cellular
In Vitro
SV2A
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm030913e
In Vivo Validations
Rat
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
1.7 h
Systemic clearance:
4.67 mL/min/kg
Tmax:
0.5 h
Bioavailability:
~100%
DOI Reference: 10.1021/jm030913e
Chemical Information
| Molecular Formula | C11H20N2O2 |
| SMILEs | CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1 |
| InChI | InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1 |
| Molecular weight | 212.15 Da |
| AlogP | 0.0 |
| HBond acceptors | 4 |
| HBond donors | 2 |
| Atoms | 35 |